339 related articles for article (PubMed ID: 18175430)
1. [Diagnostic importance and pitfalls of evaluating bone marrow smear preparation in multiple myeloma].
Scudla V; Adam Z
Vnitr Lek; 2006 Nov; 52 Suppl 2():55-65. PubMed ID: 18175430
[TBL] [Abstract][Full Text] [Related]
2. [Options for histological examination of bone marrow during diagnosis of multiple myeloma].
Fabian P; Moulis M
Vnitr Lek; 2006 Nov; 52 Suppl 2():66-70. PubMed ID: 18175431
[TBL] [Abstract][Full Text] [Related]
3. [Monoclonal gammopathies: differential diagnosis with bone marrow biopsy].
Faravelli A; Ponzoni M; Zoldan MC; Ricci D; Camba L
Pathologica; 1994 Jun; 86(3):258-66. PubMed ID: 7808796
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow evaluation: the relative merits of particle sections and smear preparations.
Cetto GL; Iannucci A; Perini A; Capitanio A; Alloush N; Fiore-Donati L
Appl Pathol; 1983; 1(4):181-93. PubMed ID: 6432009
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the usefulness of bone marrow sections and smears in diagnosis of multiple myeloma.
Buss DH; Prichard RW; Hartz JW; Cooper MR
Hematol Pathol; 1987; 1(1):35-43. PubMed ID: 3504429
[TBL] [Abstract][Full Text] [Related]
6. Should bone marrow examination be routinely performed for the diagnosis of monoclonal gammopathy of undetermined significance?
Elis A; Radnay J; Shapiro H; Itzhaky D; Manor Y; Lishner M
Isr Med Assoc J; 2006 Dec; 8(12):840-2. PubMed ID: 17214099
[TBL] [Abstract][Full Text] [Related]
7. [Importance of selected laboratory indicators in the differential diagnosis and monitoring of multiple myeloma].
Maisnar V; Tousková M; Malý J; Krejsek J; Kmonícek M; Kopecký O
Vnitr Lek; 2002 Apr; 48(4):290-7. PubMed ID: 12061177
[TBL] [Abstract][Full Text] [Related]
8. Digital image analysis of mean AgNOR area objectively discriminates between reactive plasmacytosis and multiple myeloma in cytologic smears from bone marrow aspirates.
Gunia S; Mai PA; Koch S
Pathobiology; 2008; 75(5):306-11. PubMed ID: 18931533
[TBL] [Abstract][Full Text] [Related]
9. Conventional diagnostics in multiple myeloma.
San Miguel JF; Gutiérrez NC; Mateo G; Orfao A
Eur J Cancer; 2006 Jul; 42(11):1510-9. PubMed ID: 16762540
[TBL] [Abstract][Full Text] [Related]
10. Quantification of bone marrow plasma cell infiltration in multiple myeloma: usefulness of bone marrow aspirate clot with CD138 immunohistochemistry.
Matsue K; Matsue Y; Kumata K; Usui Y; Suehara Y; Fukumoto K; Fujisawa M; Narita K; Takeuchi M
Hematol Oncol; 2017 Sep; 35(3):323-328. PubMed ID: 27140172
[TBL] [Abstract][Full Text] [Related]
11. [Cell types in multiple myeloma: analysis of the correlation of bone marrow aspirates and biopsies according to 2 classifications].
de la Rosa Alcaide MA; Hernández Nieto L; Hernández García MT; Brito Barroso ML
Sangre (Barc); 1989 Aug; 34(4):313-4. PubMed ID: 2772787
[No Abstract] [Full Text] [Related]
12. [Therapeutic application of sequential bone marrow biopsy in myeloma: analysis of 13 medullary biopsies].
Paule B; Médicis P; Clerc D; Bennet P; Bisson M; Massias P
Biomed Pharmacother; 1986; 40(7):261-4. PubMed ID: 3814757
[TBL] [Abstract][Full Text] [Related]
13. Needle aspiration and biopsy in the diagnosis and monitoring of bone marrow diseases.
Hodges A; Koury MJ
Clin Lab Sci; 1996; 9(6):349-53. PubMed ID: 10165116
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow examination: techniques and interpretation.
Hyun BH; Gulati GL; Ashton JK
Hematol Oncol Clin North Am; 1988 Dec; 2(4):513-23. PubMed ID: 3065315
[TBL] [Abstract][Full Text] [Related]
15. Diverse niches within multiple myeloma bone marrow aspirates affect plasma cell enumeration.
Nadav L; Katz BZ; Baron S; Yossipov L; Polliack A; Deutsch V; Geiger B; Naparstek E
Br J Haematol; 2006 Jun; 133(5):530-2. PubMed ID: 16681641
[TBL] [Abstract][Full Text] [Related]
16. [The CBO professional guideline 'monoclonal gammopathy' (paraproteinemia) (revision)].
Buiting AM; Wijermans PW
Ned Tijdschr Geneeskd; 2002 Jul; 146(30):1406-11. PubMed ID: 12174434
[TBL] [Abstract][Full Text] [Related]
17. Significance of bone marrow fibrosis in multiple myeloma.
Subramanian R; Basu D; Dutta TK
Pathology; 2007 Oct; 39(5):512-5. PubMed ID: 17886102
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow trephine combined with immunohistochemistry is superior to bone marrow aspirate in follow-up of myeloma patients.
Joshi R; Horncastle D; Elderfield K; Lampert I; Rahemtulla A; Naresh KN
J Clin Pathol; 2008 Feb; 61(2):213-6. PubMed ID: 17526802
[TBL] [Abstract][Full Text] [Related]
19. Fundamentals of bone marrow examination.
Hyun BH; Stevenson AJ; Hanau CA
Hematol Oncol Clin North Am; 1994 Aug; 8(4):651-63. PubMed ID: 7525532
[TBL] [Abstract][Full Text] [Related]
20. The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells.
Ng AP; Wei A; Bhurani D; Chapple P; Feleppa F; Juneja S
Haematologica; 2006 Jul; 91(7):972-5. PubMed ID: 16818287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
